Human recombinant apyrase therapy protects against canine pulmonary ischemia-reperfusion injury.
about
Mechanisms of lung ischemia-reperfusion injury.5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway.Primary graft dysfunction: pathophysiology to guide new preventive therapies.Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Mechanisms: A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation.Pannexin-1 channels on endothelial cells mediate vascular inflammation during lung ischemia-reperfusion injury
P2860
Human recombinant apyrase therapy protects against canine pulmonary ischemia-reperfusion injury.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Human recombinant apyrase ther ...... y ischemia-reperfusion injury.
@ast
Human recombinant apyrase ther ...... y ischemia-reperfusion injury.
@en
type
label
Human recombinant apyrase ther ...... y ischemia-reperfusion injury.
@ast
Human recombinant apyrase ther ...... y ischemia-reperfusion injury.
@en
prefLabel
Human recombinant apyrase ther ...... y ischemia-reperfusion injury.
@ast
Human recombinant apyrase ther ...... y ischemia-reperfusion injury.
@en
P2093
P2860
P1476
Human recombinant apyrase ther ...... ry ischemia-reperfusion injury
@en
P2093
Alessandro Montecalvo
Alexander S Krupnick
Andrew E Gelman
Carlos A Puyo
Cecilia Menna
Claudio Andreetti
Daniel Kreisel
Erino A Rendina
Howard J Huang
Ramsey R Hachem
P2860
P304
P356
10.1016/J.HEALUN.2014.09.034
P577
2014-10-02T00:00:00Z